NCT00380393View on ClinicalTrials.gov

Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.

PHASE2CompletedINTERVENTIONAL
Enrollment

894

Participants

Timeline

Start Date

January 3, 2007

Primary Completion Date

August 15, 2008

Study Completion Date

November 11, 2008

Conditions
Malaria
Interventions
BIOLOGICAL

GSK malaria vaccine 257049 Vaccine

3 dose intramuscular injection

BIOLOGICAL

Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine

3 dose intramuscular injection

Trial Locations (2)

80108

GSK Investigational Site, Kilifi

Unknown

GSK Investigational Site, Amani, Tanga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY